SHL:ASX
Sonic Healthcare Ltd
A$18.66
arrow_downward
-1.74%(-0.33) 1D
Oct 1, 11:45:25 AM GMT+10 · AUD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SHL...
Open
A$18.86
High
A$18.88
Low
A$18.53
Mkt. cap
9.23B
Avg. vol.
4.34M
Volume
893.68K
Dividend
5.79%
Quarterly dividend
A$0.27
Ex-dividend date
Sep 2, 2026
P/E ratio
15.17
52-wk high
A$24.27
52-wk low
A$18.26
EPS
A$1.23
Shares outstanding
494.24M
No. of employees
45K
Open
A$18.86
High
A$18.88
Low
A$18.53
Mkt. cap
9.23B
Avg. vol.
4.34M
Volume
893.68K
Dividend
5.79%
Quarterly dividend
A$0.27
Ex-dividend date
Sep 2, 2026
P/E ratio
15.17
52-wk high
A$24.27
52-wk low
A$18.26
EPS
A$1.23
Shares outstanding
494.24M
No. of employees
45K
News stories
From web sources and news partners
Kalkine Media
·
21 hours ago
Why Are Sonic Healthcare (ASX:SHL) Shares Near a Decade Low?
Profile
Sonic Healthcare Limited is a Sydney-based, Australian company that provides laboratory services, pathology, radiology services and primary care medical services. Wikipedia
About Sonic Healthcare Ltd
CEOColin S. Goldschmidt M.D.
Employees45K
Founded1934
HeadquartersSydney, New South Wales, Australia
SectorHealth care provider
Websitesonichealthcare.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in AUD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.72B | 2.72B | 2.71B | 2.71B |
Cost of goods sold | 1.84B | 1.84B | 1.80B | 1.80B |
Cost of revenue | 1.84B | 1.84B | 1.80B | 1.80B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 84.51M | 84.51M | 79.15M | 79.15M |
Operating expense | 636.48M | 636.48M | 653.98M | 653.98M |
Total operating expenses | 2.48B | 2.48B | 2.45B | 2.45B |
Operating income | 244.41M | 244.41M | 257.56M | 257.56M |
Other non operating income | - | - | - | - |
EBT including unusual items | 188.44M | 188.44M | 223.83M | 223.83M |
EBT excluding unusual items | 192.32M | 192.32M | 207.99M | 207.99M |
Income tax expense | 49.90M | 49.90M | 44.21M | 44.21M |
Effective tax rate | 26.48% | 26.48% | 19.75% | 19.75% |
Other operating expenses | 334.84M | 334.84M | 357.44M | 357.44M |
Net income | 131.24M | 131.24M | 172.90M | 172.90M |
Net profit margin | 4.82% | 4.82% | 6.38% | 6.38% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | - | - |
Interest expense | -52.09M | -52.09M | -49.56M | -49.56M |
Net interest expenses | -52.09M | -52.09M | -49.56M | -49.56M |
Depreciation and amortization charges | 192.74M | 192.74M | 193.01M | 193.01M |
EBITDA | 461.55M | 461.55M | 474.94M | 474.94M |
Gain or loss from assets sale | - | - | - | - |